EGFR and cancer: An EGFR-downregulating peptide, Herdegradin, induced alterations in signal pathways similar to EGFR knockdown, killed cancer cells and induced mitophagy in vitro, and induced mitophagy and inhibited growth of orthotopic SKOV3 cancers in vivo